Doc Code: PA”
`Document Description: Power of Attorney
`
`PTO/AlA/82A (07-13)
`Approved for use through 11/30/2014, OMB 0651—0051
`US, Patent and Trademark Office; US DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it displays a valid OMB control number
`
`NOTE: This form is to be submitted with the Power of Attorney by Applicant form (PTO/AlA/BzB) to identify the application to which the
`Power of Attorney is directed, in accordance with 37 CFR 1.5, unless the application number and filing date are identified in the Power of
`Attorney by Applicant form.
`If neither form PTO/AlA/82A nor form PTO/AlA82B identifies the application to which the Power of Attorney is
`directed, the Power of Attorney will not be recognized in the application.
`
`13/627,811
`
`Filing Date
`
`September 26, 2012
`
`First Named inventor
`
`Yukari HATAOKA
`
`Examiner Name
`
`Chih Min KAM
`
`069804-0349
`
` TRANSMITTAL FOR POWER OF ATTORNEY TO ONE OR MORE
`
`REGISTERED PRACTITIONERS
`
`
`
` Application Number
`
`
`
`
`
`Title
`
`
`
`METHOD FOR IMMOBILIZING GLUCOSE OXIDASE ON A SELF-
`ASSEMBLED MONOLAYER
`
`
`Art Unit
`1656
`
`
`
`
`
`
`
`
`
`Attorney Docket Number
`
`
`SIGNATURE of Applicant or Patent Practitioner
`
`Signature
`
`Registration
`Number
`
`DM_US 58061641-1069804. 0374
`
`/Michael E. Fogarty/
`
`January 13, 2015
`
`
`
`
`Name
`
`
`
`36,139
`Michael E. Fogarty
`
`
`
`
` Title (if Applicant is
`a juristic entity)
`Applicant Name (if Applicant is a juristic entity)
`
`NOTE: This form must be signed in accordance with 37 CFR 133. See 37 CFR 1.4(d) for signature requirements and certifications. if more than
`
`
`one applicant, use multiple forms.
`
`
` D *Total of
`1
`forms are submitted,
`
`

`

`). )é‘n‘gé
`
`Promwoze (07 13)
`DOC Code: PA.
`Approved for use through 1i!30]2014,0MB 0651-0051
`Document Description: Power Of Attorney
`U.S‘ Patent and Trademark om U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1955. no persons are required to respond to a ootiacticn of information unless it displays a valid OMB contra: number
`
`POWER OF ATTORNEY BY APPLICANT
`
`
`
`
`
`
`
`
`
`
`l hereby revoke all previous powers of attorney given in the application identified in either the attached transmittal letter or
`
`
`the boxes below.
`
`
`Application Number
`Filing Date
`
`
`
`(Note: The boxes above may be left blank iiintonnation is provided on form PTO/AWBZA.)
`
`
`I hereby appoint the Patent Practitionerts) associated with the following Customer Number as my/our attorneyts) or agant(s). and
`
`
`to transact all business in the United States Patent and Trademark Office connected therewith for the application referenced in
`the attached transmittal letter (form PTO/AINBZA) or identified above:
`“WMW‘WM’”
`
`OR
`{20277
`J
`
`
`[:1 l hereby appoint Practitioner(s) named in the attached list (form PTO/AWBZC) as my/our attorney(s) or agentps). and to transact
`all business in the United States Patent and Trademark Office connected therewith for the patent application referenced in the
`
`attached transmittal letter (form PTO/AiA/BZA) or identified above.
`(Note: Complete form PTOJAiA/BZC.)
` Please recognize or change the correspondence address for the application identified in the attached transmittal
`
`
`letter or the boxes above to:
`The address associated with the above-mentioned Customer Number
`
`
`OR
`
`B The address associated with Customer Number. lwWW:, gall
`Firm or
`Individual Name
`
`—”—_
`-—
`
`Telephone -m
`i am the Applicant (it the Appiicant is a )uristic entity, list the Applicant name in the box):
`
`
`
`
`
`
`
`
`
`
`
`
`[PANASONIC HEALTHCARE HOLDINGS CO., LTD.
`D Inventor or Joint Inventor (title not required below)
`[3 Legal Representative of a Deceased or Legally incapacitated inventor (title not required below)
`Assignee or Person to Whom the Inventor is Under an Obligation to Assign (provide signer‘s title it applicant is a iuristic entity)
`[:1 Person Who Otherwise Shows Sufficient Proprietary Interest (69.. a petition under 37 CFR ‘i.46(b)(2) was granted in the
`apiication or is concurrentl bern- filed with this document
`-rovide siners title if a licant is a ’uristic anti
`_
`,SIGNATURE of Applicant for Patent
`
`l
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`The undersigned (whoseItitleIs suppliad below)Is authorized to act on behalf of the applicant (a. 9. where theapplicantIs a iunslicentity) _
`
`”W Dateismear
`22. :9“ 20/
`
`President PANASONIC HEALTHCARE HOLDINGS co” LTD
`flOTE: Signature- This form must be 5!good by the applicaniIn accordance with 37 CFR 1. 33. See 37 CFR t 4 for signature requirements
`and certifications. if more than one applicant, use muitiple forms.
`
`forms are submitted.
`Dfotai of
`this cotteotton oi mtonnation to mouthed by 33' CPR t tsi. 1.32 and 1 33 The information is required to obtain or retain a benefit try the {white whichto to me {and a}! the
`USPTO 1° process) an application. Confidentiality Ia governed by 36 {1.8.8. 122 and 37 CFR t it and 1.14. This collection is ashmated to take 3 minutes to complete.
`including gathemp. preparing. and submitting the completed appiication form to the USPTO. Time Will vary depending upon the indwiouei case. Any comments on the amount
`of time you require to compiete this form endlor suggestions for reducing this burden. should be sent to the Chiei iniorrnation Officer) US Patent and Trademark Office. U.S.
`Department at Commerce. P 0. Box 1460. Alexandria. VA 2231191450. 00 NOT SEND FEES OR COMPLETED FORMS TO THIS ADDRESS) SEND TO: Commissioner
`for Patents, PD. Box 1460‘ Alexandria. VA 22313-1460.
`ifyou need assistance in completing the form. oat! 1-800vPTO-9199 and select option 2.
`
`
`
`
`